Ana Montaño-Rodriguez
University of Helsinki(FI)Helsinki Institute of Physics(FI)
Publications by Year
Research Areas
Nerve injury and regeneration, Chromium effects and bioremediation, Neurotransmitter Receptor Influence on Behavior, Renal cell carcinoma treatment, Neurogenesis and neuroplasticity mechanisms
Most-Cited Works
- → Antigenotoxic Effects of (–)-Epigallocatechin-3-Gallate (EGCG), Quercetin, and Rutin on Chromium Trioxide-Induced Micronuclei in the Polychromatic Erythrocytes of Mouse Peripheral Blood(2014)44 cited
- → Elevated endogenous GDNF induces altered dopamine signalling in mice and correlates with clinical severity in schizophrenia(2022)37 cited
- → Postnatal prolongation of mammalian nephrogenesis by excess fetal GDNF(2021)17 cited
- → Modulation of hexavalent chromium-induced genotoxic damage in peripheral blood of mice by epigallocatechin-3-gallate (EGCG) and its relationship to the apoptotic activity(2015)17 cited
- → Analysis of Acute and Chronic Methamphetamine Treatment in Mice on Gdnf System Expression Reveals a Potential Mechanism of Schizophrenia Susceptibility(2023)7 cited
- → Striatal GDNF Neurons Chemoattract RET-Positive Dopamine Axons at Seven Times Farther Distance Than Medium Spiny Neurons(2024)4 cited
- → Nicotinamide riboside first alleviates symptoms but later downregulates dopamine metabolism in proteasome inhibition mouse model of Parkinson's disease(2024)4 cited
- → Gene Knock Up via 3’UTR editing to study gene function in vivo(2019)4 cited
- → Nicotinamide riboside alleviates Parkinson’s disease symptoms but downregulates dopamine metabolism upon lactacystin-induced proteostasis failure(2021)3 cited
- → Efecto genotóxico y citotóxico de la exposición a metales pesados (cromo [VI] y talio [I]) en ratones de la cepa CD-1: micronúcleos, apoptosis y viabilidad celular(2015)3 cited